ArticleAccident; analysis and prevention2021
Simulated driving performance among daily and occasional cannabis users.
Article in Accident; analysis and prevention, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07176208 (Dose Ranging Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol), which is not on this map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Dose Ranging Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults
Who cites it
24 citing papers in PubMed, 42 citations in OpenAlex.
- Can inhaled cannabis users accurately evaluate impaired driving ability? A randomized controlled trial.Frontiers in public health · 2023Trial
- The use of THC cutoff levels in blood and oral fluid for detecting impairment in frequent cannabis users who smoked cannabis the "evening before".Psychopharmacology · 2026Article
- Short-term residual effects of smoked cannabis on simulated driving performance.Psychopharmacology · 2026Article
- The effects of orally ingested Delta-9-Tetrahydrocannabinol on drivers' hazard perception and risk-taking behaviours: A within-subjects study of medicinal cannabis users.Psychopharmacology · 2026Article
- Edible cannabis use on simulated driving performance.Traffic injury prevention · 2026Article
- Hospitalization for carbon monoxide poisoning is associated with substance use and mood disorders.Internal and emergency medicine · 2025Article
- Impact of naturalistic cannabis use on lateral control and speed: A driving simulator study.Traffic injury prevention · 2025Article
- The driving-related attitudes, beliefs and behaviours of cannabis users in the Australian Capital Territory following decriminalisation.Drug and alcohol review · 2025Article
- Changes in and correlates of cannabis-involved substance use treatment admissions age 50 and older, 2000-2021.Frontiers in public health · 2025Article
- Cannabinoids detected in exhaled breath condensate after cannabis use.Journal of breath research · 2024Article
- Effects of acute cannabis inhalation on reaction time, decision-making, and memory using a tablet-based application.Journal of cannabis research · 2024Article
- Cannabis and Driving in Older Adults.JAMA network open · 2024Article
- Accuracy and replicability of identifying eyelid tremor as an indicator of recent cannabis smoking.Clinical toxicology (Philadelphia, Pa.) · 2024Article
- Effects of kratom on driving: Results from a cross-sectional survey, ecological momentary assessment, and pilot simulated driving Study.Traffic injury prevention · 2024Article
- THC in breath aerosols collected with an impaction filter device before and after legal-market product inhalation-a pilot study.Journal of breath research · 2023Article
- The minor cannabinoid cannabigerol (CBG) is a highly specific blood biomarker of recent cannabis smoking.Clinical toxicology (Philadelphia, Pa.) · 2023Observational
- Blood cannabinoid molar metabolite ratios are superior to blood THC as an indicator of recent cannabis smoking.Clinical toxicology (Philadelphia, Pa.) · 2023Observational
- Interpol review of toxicology 2019-2022.Forensic science international. Synergy · 2023Review
- A Latent Variable Analysis of Psychomotor and Neurocognitive Performance After Acute Cannabis Smoking.Cannabis (Albuquerque, N.M.) · 2023Article
- Tonic Endocannabinoid Levels Modulate Retinal Signaling.International journal of environmental research and public health · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 6 institutions in 1 country.
Funding
Abstract
objectiveDaily cannabis users develop tolerance to some drug effects, but the extent to which this diminishes driving impairment is uncertain. This study compared the impact of acute cannabis use on driving performance in occasional and daily cannabis users using a driving simulator.
methodsWe used a within-subjects design to observe driving performance in adults age 25 to 45 years with different cannabis use histories. Eighty-five participants (43 males, 42 females) were included in the final analysis: 24 occasional users (1 to 2 times per week), 31 daily users and 30 non-users. A car-based driving simulator (MiniSim™, National Advanced Driving Simulator) was used to obtain two measures of driving performance, standard deviation of lateral placement (SDLP) and speed relative to posted speed limit, in simulated urban driving scenarios at baseline and 30 min after a 15 min ad libitum cannabis smoking period. Participants smoked self-supplied cannabis flower product (15% to 30% tetrahydrocannabinol (THC). Blood samples were collected before and after smoking (30 min after the start of smoking). Non-users performed the same driving scenarios before and after an equivalent rest interval. Changes in driving performance were analyzed by repeated measures general linear models.
resultsMean whole blood THC cannabinoids concentrations post smoking were use THC = 6.4 ± 5.6 ng/ml, THC-COOH = 10.9 ± 8.79 ng/mL for occasional users and THC = 36.4 ± 37.4 ng/mL, THC-COOH = 98.1 ± 90.6 ng/mL for daily users. On a scale of 0 to 100, the mean post-use score of subjective high was similar in occasional users and daily users (52.4 and 47.2, respectively). In covariate-adjusted analysis, occasional users had a significant increase in SDLP in the straight road segment from pre to post compared to non-users; non-users decreased by a mean of 1.1 cm (25.5 cm to 24.4 cm) while occasional users increased by a mean of 1.9 cm (21.7 cm to 23.6 cm; p = 0.02). Daily users also increased adjusted SDLP in straight road segments from baseline to post-use (23.2 cm to 25.0 cm), but the change relative to non-users was not statistically significant (p = 0.08). The standardized mean difference in unadjusted SDLP from baseline to post-use in the straight road segments comparing occasional users to non-users was 0.64 (95% CI 0.09 - 1.19), a statistically significant moderate increase. When occasional users were contrasted with daily users, the baseline to post changes in SDLP were not statistically significant. Daily users exhibited a mean decrease in baseline to post-use adjusted speed in straight road segments of 1.16 mph; a significant change compared to slight speed increases in the non-users and occasional users (p = 0.02 and p = 0.01, respectively).
conclusionWe observed a decrement in driving performance assessed by SDLP after acute cannabis smoking that was statistically significant only in the occasional users in comparison to the nonusers. Direct contrasts between the occasional users and daily users in SDLP were not statistically significant. Daily users drove slower after cannabis use as compared to the occasional use group and non-users. The study results do not conclusively establish that occasional users exhibit more driving impairment than daily users when both smoke cannabis ad libitum.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.